If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

I am an applied health economist at the Australian Institute of Health Innovation (AIHI). I joined Macquarie University as a post-doctoral Fellow after being awarded my PhD in 2015 by UNSW, and was promoted to Research Fellow in 2018. I have a unique profile through my previous experience in medicine, financial accounting, investment banking, and regulatory compliance. I qualified as a doctor in 1982 and worked in acute care before changing to a career in finance. I was awarded an MBA in 1987 while working as a financial trader in London, and an MHA in 2006 while working in investment banking in Hong Kong. In 2011 I decided to combine my interests in health and finance through pursuing an academic career in health economics.

My research has used applied health economics, econometrics and implementation science techniques to investigate and evaluate complex interventions across a wide range of health service settings: clinical governance (hospital accreditation), clinical issues (delirium, refractory epilepsy, and motor neurone disease), and medical informatics (electronic medication management systems, and point-of-care testing in rural hospitals).

I have established a strong research output with 26 published peer-reviewed papers, including 8 as first author, since 2011. I am currently evaluating the Delirium Clinical Care Standard in acute care for my NSW Health EMC Fellowship. I hold an Adjunct Senior Lecturer position at the University of Tasmania, and worked at the Centre for Health Economic Research Evaluation at the University of Technology, Sydney during my PhD.

The nature health economics research means that I need to build strong collaborative partnerships to plan and execute projects. This has been aided by my corporate experience in running a global business, and is evidenced by the wide range of grants I have been invited to contribute to. My 10-year goal is to develop a multi-disciplinary research unit to develop successful, evidence based, strategies for implementing patient safety and quality improvements in health care, and establish a robust economic evaluation framework for assessing the longer term impacts of these interventions.

Education/Academic qualification

Health Economics, PhD, The University of New South Wales

20112015

Health Administration, MHA, The University of New South Wales

20022006

Finance, MBA, City University Business School

19861987

Medicine, MBBS, St. Thomas' Hospital, London

19771982

Fingerprint Dive into the research topics where Virginia Mumford is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 37 Similar Profiles
Accreditation Medicine & Life Sciences
Health Services Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Delivery of Health Care Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences
Interviews Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
New South Wales Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2022

Research Outputs 2005 2019

Auditory training for adult cochlear implant users: a survey and cost analysis study

Reis, M., Boisvert, I., Beedell, E. & Mumford, V., 1 Nov 2019, In : Ear and Hearing. 40, 6, p. 1445-1456 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Cochlear Implants
Costs and Cost Analysis
Rehabilitation
Fees and Charges
Salaries and Fringe Benefits

Cost-effectiveness of reclassifying triptans in Australia: Application of an economic evaluation approach to regulatory decisions

Parkinson, B., Gumbie, M., Cutler, H., Gauld, N., Mumford, V. & Haywood, P., Mar 2019, In : Value in Health. 22, 3, p. 293-302 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Pharmacists
Headache Disorders

Determinants of health and wellbeing in refractory epilepsy and surgery: the Patient Reported, ImpleMentation sciEnce (PRIME) model

Rapport, F., Shih, P., Faris, M., Nikpour, A., Herkes, G., Bleasel, A., Kerr, M., Clay-Williams, R., Mumford, V. & Braithwaite, J., 1 Mar 2019, In : Epilepsy and Behavior. 92, p. 79-89 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Epilepsy
Health
Primary Health Care
Delivery of Health Care
Patient Transfer

Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challenges

Crook, A., Hogden, A., Mumford, V., Blair, I. P., Williams, K. L. & Rowe, D. B., 1 Nov 2019, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20, Supplement 1, p. 327 1 p., CMS-01.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Genetic Testing
Amyotrophic Lateral Sclerosis
Decision Making
Genetic Counseling
Interviews

Impact of Compression Therapy on Cellulitis (ICTOC) in adults with chronic oedema: a randomised controlled trial protocol

Webb, E., Neeman, T., Gaida, J., Bowden, F. J., Mumford, V. & Bissett, B., 1 Aug 2019, In : BMJ Open. 9, 8, p. 1-8 8 p., e029225.

Research output: Contribution to journalArticleResearchpeer-review

Cellulitis
Clinical Protocols
Edema
Randomized Controlled Trials
Therapeutics

Impacts

Enhancing medicine scheduling decisions through economics

Bonny Parkinson (Participant), Henry Cutler (Participant), Mutsa Gumbie (Participant), Natalie Gauld (Participant), Virginia Mumford (Participant), Philip Haywood (Participant)

Impact: Public policy impacts, Economic impacts, Quality of life impacts

Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government

Henry Cutler (Participant), Bonny Parkinson (Participant), Martin Hoyle (Participant), Mutsa Gumbie (Participant), Rachel Song (Participant), Andrew Partington (Participant), Varinder Jeet (Participant), Elizabeth Seil (Participant), Alicia Norman (Participant), Virginia Mumford (Participant), Sanjyot Vagholkar (Participant), Lisa Pont (Participant), Janaki Amin (Participant)

Impact: Quality of life impacts, Economic impacts, Public policy impacts